Published:
Last July, 66 minors died in Gambia due to acute kidney problems associated with the intake of cough syrups manufactured in India and imported into the African country through an American pharmaceutical company.
Indonesia Bans Sale of Medicinal Syrups After Death of 99 Children
Indonesian health authorities have suspended sales of medicinal syrup after 73 children died of acute kidney disorders this year.
The spokesman for the Ministry of Health, Mohammad Syahril, reported this Wednesday at a press conference that “since the end of August there has been an increase in cases of kidney failure among minors that has drawn attention”. Likewise, he highlighted that so far this year 206 cases have been reported, mostly in minor children. six years, while “previously the usual thing was one or two a month”.
The Government of the Asian country detected that 15 of the 18 medicines with liquid paracetamol and other syrups analyzed contain ethylene glycol as a dissolving agent, a component that can be toxic and cause damage to the kidneys.
The ban will remain in force until the investigation into the cause of death is complete.
Last July, 66 children died in Gambia due to acute kidney disorders associated with the intake of cough syrups manufactured in India and imported into the African nation through an American pharmaceutical company.
In In this context, researchers from the World Health Organization found “unacceptable” levels in four products manufactured by the Indian company Maiden Pharmaceuticals 6346. of diethylene glycol and ethylene glycol.
It should be noted that Maiden Pharmaceuticals’ liquid medicines are not licensed for sale in Indonesia, while the country has banned the contaminants found in the Gambia cases.
